GO:0008637 apoptotic mitochondrial changes: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008637 apoptotic mitochondrial changes describes the morphological and physiological alterations mitochondria undergo during apoptosis, including cristae remodeling, membrane permeabilization, and release of pro-apoptotic factors [1, 6].
• The process is driven by BCL-2 family pore-forming proteins that permeabilize the mitochondrial outer membrane, a decisive step in intrinsic apoptosis.
• Mitochondrial lipid composition, especially cardiolipin and other phospholipids, facilitates apoptotic membrane reorganization and protein recruitment.
• VDAC1 and other outer membrane channels are direct targets whose closure or opening modulates apoptotic mitochondrial changes, as shown by gelsolin and A20 [3, 7].
• Dysregulated apoptotic mitochondrial changes contribute to neurodegeneration, cancer, and age-related tissue decline, making them key therapeutic targets [4, 5].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes controlling apoptotic mitochondrial changes [4, 5, 7].
Description
Apoptotic mitochondrial changes (GO:0008637) refer to the coordinated set of structural and functional alterations that mitochondria undergo when a cell commits to apoptosis. These changes include cristae remodeling, loss of mitochondrial membrane potential, outer membrane permeabilization, and the release of intermembrane space proteins such as cytochrome c [1, 6]. The term captures a biological process that is central to the intrinsic (mitochondrial) pathway of programmed cell death and is distinct from generic mitochondrial dynamics or metabolism. Researchers study GO:0008637 because it represents the point of no return in many apoptotic programs and because its dysregulation underlies diverse pathologies, from cancer to neurodegeneration [2, 4]. The morphological hallmarks of apoptotic mitochondrial changes were first linked to protease activation and TNF signaling, where A20 was shown to inhibit both mitochondrial alterations and downstream apoptotic proteases. Subsequent work identified the BCL-2 family as the principal regulators of mitochondrial outer membrane permeabilization (MOMP), a decisive event that defines this GO term. More recently, the lipid environment of the mitochondrial membrane has emerged as an active participant, with specific phospholipids promoting apoptotic facilitation. Because apoptotic mitochondrial changes are both a cause and a consequence of cellular stress, they are a focal point for therapeutic intervention. For example, targeting the overexpressed mitochondrial protein VDAC1 in Alzheimer's disease models protects against mitochondrial dysfunction and mitigates brain pathology. Similarly, age-related decline in testicular function involves changes in the mitochondrial apoptotic pathway and the unfolded protein response. These findings underscore the need for precise genetic models to dissect the causal roles of individual genes in GO:0008637.
apoptotic mitochondrial changes At A Glance
| GO ID | GO:0008637 |
|---|---|
| GO term | apoptotic mitochondrial changes |
| Ontology | biological_process |
| Synonym | none |
| Major function | Morphological and physiological alterations of mitochondria during apoptosis, including cristae remodeling, membrane permeabilization, and release of apoptotic factors |
| Related cellular component | Mitochondrial outer membrane, mitochondrial inner membrane, cristae |
| Key regulators | BCL-2 family proteins (e.g., BAX, BAK, BID), VDAC1, gelsolin, A20 |
| Associated diseases | Alzheimer's disease, cancer, age-related tissue degeneration |
| Research methods | CRISPR knockout/knock-in, live-cell imaging, proteomics, lipidomics, apoptosis assays |
What Is GO:0008637?
According to the Gene Ontology, GO:0008637 apoptotic mitochondrial changes is defined as the morphological and physiological alterations undergone by mitochondria during apoptosis. In other words, it is the collection of structural changes (such as cristae remodeling, matrix swelling, and outer membrane rupture) and functional changes (such as loss of membrane potential, altered respiration, and release of pro-apoptotic factors) that mitochondria exhibit when a cell activates the apoptotic program [1, 6]. This term is a biological process and does not include the upstream signaling events that trigger apoptosis, nor the downstream caspase activation that follows mitochondrial permeabilization, except where those events are directly tied to mitochondrial alterations.
Why Is apoptotic mitochondrial changes Important in Cell Biology?
Apoptotic mitochondrial changes are a central node in cell death regulation and a critical determinant of whether a cell survives or dies. Because MOMP and cristae remodeling are often irreversible, understanding GO:0008637 provides mechanistic insight into tissue homeostasis, development, and disease. The process is directly implicated in neurodegeneration, where mitochondrial dysfunction precedes neuronal loss, and in ageing-related organ decline, such as testicular dysfunction in ageing rats. Moreover, cancer cells frequently evade apoptosis by suppressing mitochondrial changes, making this process a prime target for therapeutic intervention. The lipid composition of mitochondria further modulates susceptibility to apoptosis, offering additional layers for pharmacological control.
• Defines the point of no return in the intrinsic apoptotic pathway, making it a key decision hub for cell survival.
• Cristae shape and respiratory chain supercomplex assembly are linked to apoptotic efficiency, connecting mitochondrial structure to function.
• Mitochondrial lipids such as cardiolipin actively facilitate apoptotic membrane reorganization.
• VDAC1 closure by gelsolin inhibits apoptotic mitochondrial changes, revealing a direct regulatory mechanism.
• A20 inhibits TNF-induced mitochondrial changes and apoptotic protease activation, linking inflammation to mitochondrial apoptosis.
• Age-related testicular decline involves the mitochondrial apoptotic pathway and unfolded protein response.
• Targeting VDAC1 in Alzheimer's disease models protects against mitochondrial dysfunction and brain pathology.
• Glucocorticoid receptor signaling in mitochondria can influence apoptotic susceptibility.
• Apoptotic mitochondrial changes are a source of biomarkers and therapeutic targets in cancer and neurodegeneration [2, 4].
• CRISPR-based models enable causal testing of genes controlling this process [4, 5, 7].
What Happens During apoptotic mitochondrial changes?
Initiation and Cristae Remodeling
In simple terms: The inner folds of mitochondria change shape early in apoptosis.
Early in apoptosis, the mitochondrial inner membrane undergoes cristae remodeling, a process that can be driven by changes in cristae shape and respiratory chain supercomplex assembly. This remodeling is thought to mobilize cytochrome c from cristae stores and facilitate its release. The morphological alterations are part of the definition of GO:0008637 and are often observed before outer membrane permeabilization [1, 6].
Mitochondrial Outer Membrane Permeabilization (MOMP)
In simple terms: The outer membrane of mitochondria becomes leaky, allowing death factors to escape.
MOMP is executed by pore-forming BCL-2 family proteins such as BAX and BAK, which oligomerize and form pores in the mitochondrial outer membrane. This event is considered the decisive step of apoptotic mitochondrial changes and leads to the release of cytochrome c and other intermembrane space proteins. A growing list of BCL-2 family proteins can mediate this poration, highlighting redundancy and context dependence.
Lipid-Mediated Facilitation
In simple terms: Fats in the mitochondrial membrane help the death machinery assemble.
Mitochondrial lipids, including cardiolipin and other phospholipids, are not passive bystanders; they facilitate apoptotic membrane reorganization and the recruitment of pro-apoptotic proteins. Lipid composition changes can alter membrane curvature and permeability, thereby promoting MOMP. This lipid-centric view expands the mechanistic scope of GO:0008637 beyond proteins alone.
Regulation by VDAC1 and Gelsolin
In simple terms: A channel protein in the outer membrane can be closed to block apoptosis.
VDAC1 is a mitochondrial outer membrane channel whose opening or closure modulates apoptotic mitochondrial changes. Human gelsolin prevents apoptosis by inhibiting these changes via closing VDAC1. Conversely, VDAC1 overexpression can exacerbate mitochondrial dysfunction in disease models, as shown in Alzheimer's disease mice where targeting VDAC1 was protective.
Inhibition by A20 and Anti-Apoptotic Signals
In simple terms: Certain proteins can put the brakes on mitochondrial death changes.
A20 inhibits TNF-induced mitochondrial changes and the activation of apoptotic proteases, demonstrating that apoptotic mitochondrial changes are subject to negative regulation. This inhibition occurs upstream or at the level of mitochondrial alterations, linking inflammatory signaling to mitochondrial apoptosis. Such regulatory checkpoints are critical for understanding how cells resist apoptosis.
Key Genes Involved in GO:0008637 apoptotic mitochondrial changes
The following genes and proteins are experimentally implicated in apoptotic mitochondrial changes (GO:0008637) based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BAX | Pore-forming BCL-2 effector that permeabilizes mitochondrial outer membrane | Central to MOMP; knockout models resist apoptosis |
| BAK | Pore-forming BCL-2 effector, redundant with BAX | Required for MOMP in many cell types |
| BID | BH3-only protein that activates BAX/BAK | Links extrinsic and intrinsic apoptosis |
| BCL-2 | Anti-apoptotic protein that inhibits MOMP | Overexpression blocks apoptotic mitochondrial changes |
| BCL-xL | Anti-apoptotic BCL-2 family member | Inhibits pore formation and cristae remodeling |
| VDAC1 | Outer membrane channel; regulates metabolite flux and apoptosis | Target in Alzheimer's disease; closed by gelsolin [4, 7] |
| Gelsolin | Actin-binding protein that closes VDAC1 | Prevents apoptosis by inhibiting mitochondrial changes |
| A20 | NF-kB inhibitory protein that blocks TNF-induced mitochondrial changes | Negative regulator of apoptotic proteases |
| Cytochrome c | Electron carrier released during MOMP | Marker of apoptotic mitochondrial changes |
| Cardiolipin synthase | Enzyme for cardiolipin synthesis | Lipid facilitator of apoptosis |
| Glucocorticoid receptor (NR3C1) | Nuclear receptor with mitochondrial actions | Modulates apoptotic susceptibility |
| OPA1 | GTPase controlling cristae shape | Cristae remodeling affects apoptosis |
| MICOS complex subunits | Maintain cristae junctions | Cristae architecture influences cytochrome c release |
| TNF | Cytokine that induces mitochondrial changes | Used to trigger apoptotic mitochondrial changes in vitro |
How Is apoptotic mitochondrial changes Regulated?
Apoptotic mitochondrial changes are regulated at multiple levels. Anti-apoptotic BCL-2 family proteins (e.g., BCL-2, BCL-xL) inhibit MOMP by sequestering pro-apoptotic effectors. BH3-only proteins sense cellular stress and activate BAX/BAK. Mitochondrial lipids, particularly cardiolipin, can promote or inhibit pore formation depending on their distribution. VDAC1 closure by gelsolin provides a direct inhibitory mechanism, while A20 suppresses TNF-induced mitochondrial alterations. Additionally, mitochondrial glucocorticoid receptor signaling can modulate apoptotic sensitivity. These regulatory layers ensure that mitochondrial apoptosis is tightly controlled and context-dependent.
apoptotic mitochondrial changes and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VDAC1 | Alzheimer's disease; mitochondrial dysfunction | Knockout or knockdown in mouse models; overexpression |
| BAX | Cancer resistance to apoptosis | Knockout cell lines; point mutations |
| BAK | Cancer resistance to apoptosis | Knockout cell lines; double knockout with BAX |
| A20 | Inflammatory signaling and apoptosis | Knockout or overexpression in TNF-treated cells |
| Gelsolin | Apoptosis inhibition | Overexpression and point mutation of VDAC1-binding domain |
Neurodegeneration
In Alzheimer's disease, overexpression of the mitochondrial protein VDAC1 is associated with mitochondrial dysfunction and brain pathology. Targeting VDAC1 in a mouse model protected against these changes, suggesting that apoptotic mitochondrial changes contribute to neurodegeneration. This positions GO:0008637 as a therapeutic target in neurodegenerative disorders.
Age-Related Tissue Decline
Ageing rats show a decline in testicular function accompanied by changes in the unfolded protein response and the mitochondrial apoptotic pathway. This indicates that apoptotic mitochondrial changes are involved in age-related organ dysfunction and may serve as biomarkers or intervention points.
Cancer
Cancer cells often evade apoptosis by upregulating anti-apoptotic BCL-2 proteins or downregulating effectors like BAX/BAK, thereby suppressing apoptotic mitochondrial changes. Understanding these mechanisms is critical for developing BH3 mimetics and other targeted therapies.
Inflammatory Signaling
TNF-induced mitochondrial changes and apoptotic protease activation are inhibited by A20, linking inflammatory pathways to mitochondrial apoptosis. Dysregulation of this crosstalk can contribute to chronic inflammation and autoimmune diseases.
From apoptotic mitochondrial changes-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of BAX prevent MOMP? | BAX knockout cell line |
| Can a point mutation in VDAC1 alter apoptosis? | VDAC1 point-mutation knock-in |
| Does overexpression of BCL-2 block apoptotic mitochondrial changes? | BCL-2 overexpression stable cell line |
| Is gelsolin's VDAC1-binding domain required for apoptosis inhibition? | Gelsolin deletion mutants and knock-in |
| How does A20 inhibit TNF-induced mitochondrial changes? | A20 knockout and tagged knock-in for imaging |
| Does cardiolipin synthase knockout affect MOMP? | CRISPR knockout of cardiolipin synthase |
How to Study the apoptotic mitochondrial changes Process
| Method | What It Measures | Typical Application |
|---|---|---|
| TMRE/JC-1 staining | Mitochondrial membrane potential | Detection of early apoptotic changes |
| Cytochrome c-GFP imaging | Release of cytochrome c from mitochondria | Live-cell monitoring of MOMP |
| Caspase-3/7 activity assay | Downstream caspase activation | Quantifying apoptosis after MOMP |
| Lipidomics | Cardiolipin and phospholipid composition | Linking lipid changes to apoptosis |
| Proteomics | Release of mitochondrial proteins | Identifying biomarkers of GO:0008637 |
| CRISPR knockout | Loss-of-function of candidate genes | Testing necessity of BAX, VDAC1, etc. [6, 7] |
| CRISPR knock-in | Tagged or mutant protein expression | Tracking localization and function |
| Overexpression | Gain-of-function | Testing sufficiency of BCL-2 or gelsolin [3, 7] |
Live-Cell Imaging of Mitochondrial Dynamics
Fluorescent probes such as TMRE or JC-1 measure mitochondrial membrane potential, while mito-GFP or cytochrome c-GFP track morphological changes and release. Time-lapse imaging captures cristae remodeling and MOMP in real time [1, 6].
Proteomics and Lipidomics
Mass spectrometry-based proteomics can quantify release of intermembrane space proteins, while lipidomics profiles cardiolipin and other phospholipids that facilitate apoptosis. These methods identify molecular signatures of GO:0008637.
Apoptosis Assays
Annexin V/PI staining, caspase-3/7 activity assays, and TUNEL staining quantify apoptotic cell death downstream of mitochondrial changes. These are standard readouts for functional validation [3, 7].
Genetic Perturbation with CRISPR
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes such as VDAC1, BAX, and A20 in apoptotic mitochondrial changes [4, 5, 7].
How CRISPR Can Be Used to Study GO:0008637 apoptotic mitochondrial changes
Knockout
CRISPR knockout of BAX, BAK, or VDAC1 can abolish or reduce apoptotic mitochondrial changes, allowing researchers to test necessity. For example, VDAC1 knockout in Alzheimer's models protects against mitochondrial dysfunction.
Point Mutation
Introducing point mutations in genes such as VDAC1 or BAX can dissect domain-specific functions, such as pore formation or channel closure, without altering protein levels [6, 7].
Knock-in
Tagged knock-in of cytochrome c or A20 enables real-time imaging and interaction studies in the context of apoptotic mitochondrial changes [3, 6].
Overexpression
Overexpression of anti-apoptotic proteins like BCL-2 or gelsolin can block apoptotic mitochondrial changes, providing gain-of-function evidence for their regulatory roles [3, 7].
How EDITGENE Supports apoptotic mitochondrial changes Research
Researchers studying apoptotic mitochondrial changes-related genes often need to determine whether a candidate gene is causally involved in mitochondrial permeabilization, cristae remodeling, or downstream apoptosis. EDITGENE provides custom CRISPR cell models and screening services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for apoptotic mitochondrial changes research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| HK2 Knockout HEK293 Cell Line | EDJ-KQ1507 | Human | 3099 | Details Get a Quote |
| ATP2A1 Knockout HEK293 Cell Line | EDJ-KQ1562 | Human | 487 | Details Get a Quote |
| BID Knockout HEK293 Cell Line | EDJ-KQ1746 | Human | 637 | Details Get a Quote |
| BAX Knockout HEK293 Cell Line | EDJ-KQ1747 | Human | 581 | Details Get a Quote |
| AIFM2 Knockout HEK293 Cell Line | EDJ-KQ2297 | Human | 84883 | Details Get a Quote |
| BIK Knockout HEK293 Cell Line | EDJ-KQ4135 | Human | 638 | Details Get a Quote |
| IFIT2 Knockout HEK293 Cell Line | EDJ-KQ4968 | Human | 3433 | Details Get a Quote |
| HK2 Knockout HCT 116 Cell Line | EDJ-KQ21127 | Human | 3099 | Details Get a Quote |
| HK2 Knockout HeLa Cell Line | EDJ-KQ21128 | Human | 3099 | Details Get a Quote |
| ATP2A1 Knockout HeLa Cell Line | EDJ-KQ19877 | Human | 487 | Details Get a Quote |
| BAX Knockout HCT 116 Cell Line | EDJ-KQ20266 | Human | 581 | Details Get a Quote |
| ATP2A1 Knockout A-549 Cell Line | EDJ-KQ21234 | Human | 487 | Details Get a Quote |
| ATP2A1 Knockout HCT 116 Cell Line | EDJ-KQ21235 | Human | 487 | Details Get a Quote |
| BID Knockout A-549 Cell Line | EDJ-KQ21611 | Human | 637 | Details Get a Quote |
| BID Knockout HCT 116 Cell Line | EDJ-KQ21612 | Human | 637 | Details Get a Quote |
Displaying Records 1 To 15 Of 33 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About apoptotic mitochondrial changes
What is GO:0008637 apoptotic mitochondrial changes?
GO:0008637 is a Gene Ontology biological process term describing the morphological and physiological alterations mitochondria undergo during apoptosis, including cristae remodeling and outer membrane permeabilization [1, 6].
What genes are involved in apoptotic mitochondrial changes?
Key genes include BAX, BAK, BID, BCL-2, BCL-xL, VDAC1, gelsolin, and A20, as shown in studies of MOMP and its regulation [3, 6, 7].
How does VDAC1 regulate apoptosis?
VDAC1 is a mitochondrial outer membrane channel; its closure by gelsolin inhibits apoptotic mitochondrial changes, while its overexpression can exacerbate dysfunction in disease models [4, 7].
What role do lipids play in apoptotic mitochondrial changes?
Mitochondrial lipids such as cardiolipin facilitate membrane reorganization and recruitment of pro-apoptotic proteins, actively promoting apoptosis.
Which diseases are linked to apoptotic mitochondrial changes?
Alzheimer's disease, cancer, age-related testicular decline, and inflammatory conditions have been associated with dysregulated apoptotic mitochondrial changes [3, 4, 5].
How can I study apoptotic mitochondrial changes in the lab?
Common methods include live-cell imaging of membrane potential and cytochrome c release, caspase assays, proteomics, lipidomics, and CRISPR-based genetic perturbation [1, 2, 6].
What is the role of BCL-2 family proteins in GO:0008637?
BCL-2 family proteins either form pores (BAX, BAK) or inhibit pore formation (BCL-2, BCL-xL), directly controlling mitochondrial outer membrane permeabilization.
Can CRISPR knockout of BAX prevent apoptosis?
Yes, BAX/BAK double knockout cells are widely used to block MOMP and apoptotic mitochondrial changes.
How does A20 inhibit apoptotic mitochondrial changes?
A20 inhibits TNF-induced mitochondrial changes and activation of apoptotic proteases, acting as a negative regulator.
What is the connection between glucocorticoid receptors and mitochondrial apoptosis?
Mitochondrial glucocorticoid receptors can modulate apoptotic susceptibility, though the exact mechanisms are still being studied.
Conclusion
Apoptotic mitochondrial changes (GO:0008637) represent a critical execution phase of intrinsic apoptosis, driven by BCL-2 family pore formers, modulated by lipids, and regulated by proteins such as VDAC1, gelsolin, and A20. Dysregulation of this process contributes to neurodegeneration, cancer, and age-related tissue decline. CRISPR-based models are indispensable for dissecting the causal roles of individual genes and for developing targeted therapies.
References
- 1. Cogliati S et al.. 2013. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency.. Cell 155(1):160-71 PMID: 24055366
- 2. Poulaki A et al.. 2022. Mitochondrial Lipids: From Membrane Organization to Apoptotic Facilitation.. Int J Mol Sci 23(7) PMID: 35409107
- 3. Wissing D et al.. 1998. TNF-induced mitochondrial changes and activation of apoptotic proteases are inhibited by A20.. Free Radic Biol Med 25(1):57-65 PMID: 9655522
- 4. Verma A et al.. 2022. Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathology.. Transl Neurodegener 11(1):58 PMID: 36578022
- 5. Zhao H et al.. 2019. Decline in testicular function in ageing rats: Changes in the unfolded protein response and mitochondrial apoptotic pathway.. Exp Gerontol 127:110721 PMID: 31491500
- 6. Moldoveanu T. 2023. Apoptotic mitochondrial poration by a growing list of pore-forming BCL-2 family proteins.. Bioessays 45(3):e2200221 PMID: 36650950
- 7. Kusano H et al.. 2000. Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC.. Oncogene 19(42):4807-14 PMID: 11039896
- 8. Kokkinopoulou I et al.. 2021. Mitochondrial Glucocorticoid Receptors and Their Actions.. Int J Mol Sci 22(11) PMID: 34205227
